| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1053477880 |
| P356 | DOI | 10.1007/S00415-016-8082-7 |
| P698 | PubMed publication ID | 26961897 |
| P5875 | ResearchGate publication ID | 297727741 |
| P50 | author | Panagiotis Zis | Q47148259 |
| P2093 | author name string | Marios Hadjivassiliou | |
| Channa Hewamadduma | |||
| Dasappaiah Ganesh Rao | |||
| Ptolemaios Georgios Sarrigiannis | |||
| P2860 | cites work | Drug therapy for chronic idiopathic axonal polyneuropathy | Q24247228 |
| Small-fiber neuropathy | Q28220711 | ||
| Standards of medical care in diabetes--2010. | Q33554238 | ||
| Chronic idiopathic polyneuropathy presenting in middle or old age: a clinical and electrophysiological study of 75 patients | Q33591880 | ||
| Chronic cryptogenic sensory polyneuropathy: clinical and laboratory characteristics | Q33635677 | ||
| Chronic idiopathic axonal polyneuropathy: a five year follow up | Q33733455 | ||
| Epidemiology of peripheral neuropathy | Q33735651 | ||
| Statins and risk of polyneuropathy: a case-control study | Q33959147 | ||
| EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision | Q34110857 | ||
| Peripheral neuropathy | Q34540918 | ||
| Is cardiovascular disease a risk factor in the development of axonal polyneuropathy? | Q35467022 | ||
| Progressive idiopathic axonal neuropathy--a comparative clinical and histopathological study with vasculitic neuropathy | Q35688440 | ||
| Do statins increase the risk of idiopathic polyneuropathy? | Q36103241 | ||
| Axonal neuropathy associated with monoclonal gammopathy of undetermined significance | Q36316949 | ||
| Chronic idiopathic axonal polyneuropathy is associated with the metabolic syndrome | Q36720383 | ||
| Idiopathic neuropathy patients are at high risk for metabolic syndrome | Q36957155 | ||
| Small- and large-fiber neuropathy after 40 years of type 1 diabetes: associations with glycemic control and advanced protein glycation: the Oslo Study | Q37278077 | ||
| Functioning of patients with chronic idiopathic axonal polyneuropathy (CIAP). | Q37478144 | ||
| Impaired glucose tolerance and metabolic syndrome in idiopathic neuropathy | Q38006758 | ||
| Idiopathic neuropathy: new paradigms, new promise. | Q38006763 | ||
| Differential diagnosis of monoclonal gammopathy of undetermined significance | Q38066929 | ||
| Chronic idiopathic axonal polyneuropathy and vitamin B6: a controlled population-based study | Q38210650 | ||
| The metabolic syndrome is an important concept in therapeutic decision-making | Q38381859 | ||
| Chronic idiopathic ataxic neuropathy | Q41922352 | ||
| Thickness of endoneurial vessel basal lamina area in chronic idiopathic axonal polyneuropathy | Q42493266 | ||
| Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy | Q43687920 | ||
| Painful sensory polyneuropathy associated with impaired glucose tolerance | Q43700618 | ||
| The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy | Q43700620 | ||
| The spectrum of neuropathy in diabetes and impaired glucose tolerance | Q44276740 | ||
| Increase of sural nerve T cells in progressive axonal polyneuropathy and monoclonal gammopathy | Q44578348 | ||
| Treatment of idiopathic chronic polyneuropathy with plasma exchange alone. | Q44767290 | ||
| The diagnostic yield of a standardized approach to idiopathic sensory-predominant neuropathy | Q44890977 | ||
| A controlled investigation of the cause of chronic idiopathic axonal polyneuropathy | Q44939621 | ||
| Progression in idiopathic, diabetic, paraproteinemic, alcoholic, and B12 deficiency neuropathy | Q45051940 | ||
| Idiopathic polyneuropathy and impaired glucose metabolism in a Norwegian patient series | Q46543880 | ||
| An open-label study of the lidocaine patch 5% in painful idiopathic sensory polyneuropathy | Q46787750 | ||
| Perceived control is a concurrent predictor of activity limitations in patients with chronic idiopathic axonal polyneuropathy | Q48418751 | ||
| Differences between hereditary motor and sensory neuropathy type 2 and chronic idiopathic axonal neuropathy. A clinical and electrophysiological study | Q48691929 | ||
| Impaired glucose tolerance and metabolic syndrome in idiopathic polyneuropathy: the role of pain and depression | Q48925416 | ||
| Chronic idiopathic axonal polyneuropathy. Comparison of patients with and without monoclonal gammopathy | Q49022231 | ||
| Is there a need for long-term follow-up in chronic idiopathic polyneuropathy? | Q49038727 | ||
| Quality of life in patients with axonal polyneuropathy. | Q51081227 | ||
| Value of the oral glucose tolerance test in the evaluation of chronic idiopathic axonal polyneuropathy. | Q51496559 | ||
| Health-related quality of life in patients with cryptogenic polyneuropathy compared with the general population | Q51843458 | ||
| Occupational determinants of cryptogenic polyneuropathy. | Q51945000 | ||
| Chronic progressive steroid responsive axonal polyneuropathy: A CIDP variant or a primary axonal disorder? | Q59389256 | ||
| Humoral abnormalities in three patients with idiopathic chronic polyneuropathy | Q61762733 | ||
| Prevalence of peripheral neuropathy in the Parsi community of Bombay | Q68248080 | ||
| Idiopathic polyneuropathy. A prospective study including gastrointestinal investigation | Q68673746 | ||
| Chronic progressive sensory ataxic neuropathy: clinicopathological features of idiopathic and Sjögren's syndrome-associated cases | Q70536958 | ||
| Chronic symmetric symptomatic polyneuropathy in the elderly: a field screening investigation in two Italian regions. I. Prevalence and general characteristics of the sample. Italian General Practitioner Study Group (IGPSG) | Q71525400 | ||
| Immunoglobulin therapy for idiopathic chronic sensory ataxic neuropathy | Q73484243 | ||
| Antibody panels in idiopathic polyneuropathy and motor neuron disease | Q73766482 | ||
| Sensory-predominant, painful, idiopathic neuropathy: inflammatory changes in sural nerves | Q74719054 | ||
| Dominant T-cell clones of unknown significance in patients with idiopathic sensory neuropathies | Q77114337 | ||
| Chronic idiopathic axonal polyneuropathy and successful aging of the peripheral nervous system in elderly people | Q77898662 | ||
| Chronic idiopathic axonal polyneuropathy revisited | Q80573202 | ||
| Cryptogenic polyneuropathy: clinical and neurophysiological findings | Q81385517 | ||
| Dyslipidaemia in chronic acquired distal axonal polyneuropathy | Q83435993 | ||
| Pain in patients with chronic idiopathic axonal polyneuropathy | Q84572560 | ||
| Asymmetric sensory ganglionopathy: a case series | Q86912547 | ||
| Elevated blood mercury levels in idiopathic axonal neuropathy | Q87104089 | ||
| P433 | issue | 10 | |
| P921 | main subject | systematic review | Q1504425 |
| Chronic idiopathic axonal polyneuropathy | Q19987054 | ||
| P304 | page(s) | 1903-1910 | |
| P577 | publication date | 2016-03-09 | |
| P1433 | published in | Journal of Neurology | Q6295649 |
| P1476 | title | Chronic idiopathic axonal polyneuropathy: a systematic review | |
| P478 | volume | 263 |
| Q42366171 | A prospective, observational study of patients with uncommon distal symmetric painful small-fiber neuropathy. |
| Q93361538 | Alcohol-related peripheral neuropathy: a systematic review and meta-analysis |
| Q40879930 | Cerebellar ataxia and sensory ganglionopathy associated with light-chain myeloma |
| Q47212036 | Cerebellar ataxia with sensory ganglionopathy; does autoimmunity have a role to play? |
| Q64942897 | Chronic idiopathic axonal polyneuropathy: Prevalence of pain and impact on quality of life. |
| Q33610019 | Depression and chronic pain in the elderly: links and management challenges. |
| Q90388033 | Gluten neuropathy: prevalence of neuropathic pain and the role of gluten-free diet |
| Q92826292 | Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease |
| Q57476569 | Immune-mediated neuropathies |
| Q57803953 | Increased Oxidative Stress as a Risk Factor in Chronic Idiopathic Axonal Polyneuropathy |
| Q50352521 | Microangiopathy-A Potential Contributing Factor to Idiopathic Polyneuropathy: A Mini Review |
| Q38698141 | Pain as a First Manifestation of Paraneoplastic Neuropathies: A Systematic Review and Meta-Analysis |
| Q92763913 | Pain in Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Systematic Review and Meta-Analysis |
| Q48192466 | Pain in Platin-Induced Neuropathies: A Systematic Review and Meta-Analysis |
| Q47127416 | Painful Peripheral Neuropathy and Cancer |
| Q58775562 | Peripheral Nervous System Involvement in Lymphoproliferative Disorders |
| Q64911174 | Quality of Life in Painful Peripheral Neuropathies: A Systematic Review. |
| Q55515032 | Quality of Life in Patients with Gluten Neuropathy: A Case-Controlled Study. |
| Q47148212 | Rapid neurophysiological screening for sensory ganglionopathy: A novel approach |
| Q39162433 | Validation of the Greek Version of the Fibromyalgia Rapid Screening Tool |
| Q89586330 | [Polyneuropathy in older individuals] |
Search more.